About Lawrence Miller
Lawrence Miller is a director at Apnimed.
Lawrence Miller reports to the SEC as a director or major shareholder of 2 public companies, including Tetraphase Pharmaceuticals (TTPH).
Lawrence Miller first appears on SEC filings in 2013.
Experience
This experience comes from Lawrence Miller's profile and from SEC filings. For roles taken from filings, the years are when the filings name Lawrence Miller in the role, so the role may have started earlier or lasted longer.
Apnimed, Inc. Current
Founder, former CEO and Board Vice Chair
2018 – Present · Public company (APMD)
Develops oral medicines for people with sleep apnea and other sleep-related breathing diseases.
MP
Macrolide Pharmaceuticals
Founder, CEO and Board member
2015 – 2018
AI
Activate Networks, Inc.
Founder, CEO and Board Chair
2010 – 2015
TI
Tetraphase Pharmaceuticals Inc.
10% owner
Founder, Founding CEO and Board Chair (2006 – 2012)
2006 – 2013 · Public company (TTPH)
ME
Mediphase
Founder, General Partner and President, Mediphase Management Co.
1999 – 2010
SE
Serenex
Founder, Board member
2004 – 2008
IM
ImpactRx
Founder, Board member
2002 – 2008
OR
Optio Research
Founder, Board member
2005 – 2007
PH
PharMetrics
Founder, Founding CEO and Board Chair
2000 – 2006
HM
Hambrecht and Quist Capital Management
Senior Vice President
1997 – 1999
AS
Avicenna Systems
COO
1996 – 1997
HH
HPR, Inc. (NASDAQ:HPRI)
Vice President, Medical Director
1990 – 1996
Key Colleagues at Startups
The people Lawrence Miller works with at each company, as listed on that company's latest Form D.
Apnimed, Inc. · Form D, Mar 27, 2026
Paul Fonteyne
Director
DM
Dennis Molnar
Executive officer
Barry Wohl
Chief Business Officer
JA
Joseph Avellone
Director
FB
Francois Beaubien
Director
Chris Dimitropoulos
Director
KL
Kevin Lind
Chief Executive Officer and director
IC
Isaac Cheng
Director
GS
Gary Sender
Director
RB
Ramzi Benamar
Chief Financial Officer